Lee Ainslie Heska Corp Transaction History

Maverick Capital LTD

  • $4.82 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$156.0 - $265.78 $224,952 - $383,254
-1,442 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$228.69 - $274.2 $329,770 - $395,396
1,442 New
1,442 $373,000

Others Institutions Holding HSKA

# of Institutions
4
Shares Held
26K
Call Options Held
0
Put Options Held
0
View Full List

About HESKA CORP

HSKA Quotes by TradingView
  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email